Cleared Abbreviated

K011823 - BIOREHAB SYSTEM

K011823 is an FDA 510(k) clearance for BIOREHAB SYSTEM, manufactured by Nicolet Biomedical, Inc.. The device is a Class 2 Neurology device with product code HCC cleared through the Abbreviated 510(k) pathway after a 87-day FDA review.

K011823 · Nicolet Biomedical, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2001
Decision
87d
Days
Class 2
Risk

K011823 is an FDA 510(k) clearance for the BIOREHAB SYSTEM. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Nicolet Biomedical, Inc. (Stoughton, US). The FDA issued a Cleared decision on September 6, 2001 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Nicolet Biomedical, Inc. devices

FDA 510(k) Submission Details - K011823

510(k) Number K011823 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 2001
Decision Date September 06, 2001
Days to Decision 87 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 149d · This submission: 87d
Pathway characteristics
Standards-based clearance path.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 66
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K011823.
EAR MUFFINS
K012384 · Bio-Logic Systems Corp. · Oct 2001
MODIFICATION TO A620 EEG
K012011 · Stoelting Co. · Oct 2001
INSIGHT MILLENNIUM PLUS
K011964 · Fasstech · Sep 2001
INSIGHT GENESIS
K011983 · Fasstech · Aug 2001
REGAIN DESKTOP
K003127 · Srs Medical Systems, Inc. · Jan 2001
ORION PLATINUM
K003367 · Srs Medical Systems, Inc. · Jan 2001